Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Monge who wrote (3264)	12/9/1997 8:55:00 PM
From: Izzy	Read Replies (1) \| Respond to of 6136

Short term, is this a good stock to hold?

To: Richard Monge who wrote (3264)	12/9/1997 9:17:00 PM
From: Oliver & Co	Read Replies (1) \| Respond to of 6136

I would think so. Look at this. ====================================================================== Lawsuit Fears, Cash Crunch Hit AIDS Vaccine Hunt" Reuters (12/08/97); Bunce, Matthew ÿÿÿÿ UNAIDS director Peter Piot says the search for an AIDS vaccine is being hampered by a fear of litigation and a perception in the pharmaceutical industry that such a product might not be profitable.ÿ If an AIDS vaccine is developed, Piot noted, there will be cases where it does not work and paying compensation to people for whom a vaccine fails could ruin a drug maker.ÿ Piot added, however, that an AIDS vaccine is necessary and should remain a long-term goal.ÿ He also called for an international AIDS therapy solidarity fund to help Africa deal with a large increase in the number of people infected with HIV.